These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 23359789)
1. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model. Bo H; Gao L; Chen Y; Zhang J; Zhu M Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409 [TBL] [Abstract][Full Text] [Related]
4. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. Wei W; Sun HH; Li N; Li HY; Li X; Li Q; Shen XH Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):529-38. PubMed ID: 25308364 [TBL] [Abstract][Full Text] [Related]
5. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781 [TBL] [Abstract][Full Text] [Related]
6. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740 [TBL] [Abstract][Full Text] [Related]
7. Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling. Kim J; Kim DW; Chang W; Choe J; Kim J; Park CS; Song K; Lee I J Immunol; 2012 Jan; 188(1):182-9. PubMed ID: 22124122 [TBL] [Abstract][Full Text] [Related]
8. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518 [TBL] [Abstract][Full Text] [Related]
13. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer. Yu L; Li X; Li H; Chen H; Liu H Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517 [TBL] [Abstract][Full Text] [Related]
14. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780 [TBL] [Abstract][Full Text] [Related]
15. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells. Zhang Z; Gao S; Xu Y; Zhao C Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200805 [TBL] [Abstract][Full Text] [Related]
16. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606 [TBL] [Abstract][Full Text] [Related]
17. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice. Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752 [TBL] [Abstract][Full Text] [Related]
18. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234 [TBL] [Abstract][Full Text] [Related]
19. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Vuga LJ; Ben-Yehudah A; Kovkarova-Naumovski E; Oriss T; Gibson KF; Feghali-Bostwick C; Kaminski N Am J Respir Cell Mol Biol; 2009 Nov; 41(5):583-9. PubMed ID: 19251946 [TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. Ghosh MC; Collins GD; Vandanmagsar B; Patel K; Brill M; Carter A; Lustig A; Becker KG; Wood WW; Emeche CD; French AD; O'Connell MP; Xu M; Weeraratna AT; Taub DD Blood; 2009 Aug; 114(7):1366-73. PubMed ID: 19520808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]